The format for the submission of information on medicines is published
pharmafile | July 25, 2011 | News story | |Â Â Â
The European Medicines Agency has recently published the format in which pharmaceutical companies will need to submit information regarding authorised medicines or medicines registered in the EU to satisfy the new Pharmacovigilance legislation. The format details the information which will need to be submitted to meet the legal deadline of 2nd July 2012.
Wainwright Associates can help companies plan and prepare for these future changes including the electronic submission of information which is due to start later this year.
Whether you have new or established medicinal products on the market, planning a new marketing authorisation or working with investigational medicinal products, the team at Wainwright Associates have the experience, knowledge and capability to help you in meeting your pharmacovigilance obligations. We will work with you to suit your requirements, whether it is on an ongoing basis or to addressing a single specific need.
If you would like to discuss your pharmacovigilance requirements, please contact us at enquiries@wainwrightassociates.co.uk or telephone +44 (0)1628 530554.






